BRIEF published on 06/18/2024 at 13:52, 1 year 5 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
BRIEF published on 06/18/2024 at 13:52, 1 year 5 months ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
PRESS RELEASE published on 06/18/2024 at 13:47, 1 year 5 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 1 year 6 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
BRIEF published on 05/23/2024 at 09:17, 1 year 6 months ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 6 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 1 year 7 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
BRIEF published on 04/25/2024 at 07:26, 1 year 7 months ago Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024 Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
PRESS RELEASE published on 04/25/2024 at 07:21, 1 year 7 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 1 year 8 months ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
Published on 12/05/2025 at 15:35, 15 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:00, 50 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 50 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 50 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 15:39, 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Published on 12/05/2025 at 15:38, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/05/2025 at 15:36, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 12/05/2025 at 15:35, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/05/2025 at 15:10, 39 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 39 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 51 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 5 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 5 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
